Death and Venous Thromboembolism Analyses among Hospitalized COVID-19-Positive Patients: A Multicenter Study

• Published in: Journal of clinical medicine 2023-12, Vol.12 (24), p.7624
• Main Authors: Alshahrani, Asma, Almoahzieie, Abdullah, Alshareef, Hanan, Alammash, Buthinah B, Alhamidi, Sarah, Meraya, Abdulkarim M, Alshammari, Abdullah S, Ajlan, Aziza, Alghofaili, Alnajla, Alnassar, Abdullah, Alshahrani, Nada, Aldossari, Maram, Alkhaldi, Turkiah, Alwazzeh, Marwan J, Almashouf, Abdullah B, Alkuwaiti, Feras A, Alghamdi, Shrouq Hamed, Alshehri, Ohuod, Ali, Mostafa
• Format: Article
• Language: English
• Subjects: Anticoagulants; Beta blockers; Blood diseases; Body mass index; Cancer; Cardiovascular disease; Clinical medicine; Data collection; Demographic aspects; Diabetes; Heart failure; Hospitals; Hypertension; Infections; Intensive care; Ischemia; Kidney diseases; Laboratories; Liver diseases; Metabolic disorders; Mortality; Patients; Regression analysis; Risk factors; Statistical analysis; Thromboembolism; Thyroid gland; Ventilators
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12247624

Coagulation disorders are frequently encountered among patients infected with coronavirus disease 2019 (COVID-19), especially among admitted patients with more severe symptoms. This study aims to determine the mortality rate and incidence and risk factors for venous thromboembolism (VTE) in hospitalized patients with COVID-19. This retrospective observational cohort study was conducted from March to July 2020 using a hospital database. All adult patients (>18 years old) with laboratory-confirmed COVID-19 were included. Laboratory data and the real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) for SARS-CoV-2 were obtained from medical records. The mortality rate and the incidence of VTE were established as study results. A multivariate logistic regression analysis was performed to identify predictors of thrombotic events. rA total of 1024 confirmed COVID-19 patients were treated, of whom 110 (10.7%) were deceased and 58 patients (5.7%) developed VTE. Death occurred more frequently in patients older than 50 years and those admitted to the intensive care unit (ICU, 95%) and who received mechanical ventilation (62.7%). Multivariate analysis revealed that cancer patients were two times more likely to have VTE (adjusted odds ratio = 2.614; 95% CI = (1.048-6.519); = 0.039). Other chronic diseases, such as diabetes, hypertension, and chronic kidney disease, were not associated with an increased risk of VTE. One-tenth of hospitalized COVID-19 patients were deceased, and VTE was prevalent among patients with chronic conditions, such as cancer, despite anticoagulation therapy. Healthcare professionals should closely monitor individuals with a high risk of developing VTE to prevent unwanted complications.